HOLON, Israel (AP) _ Compugen Ltd. (CGEN) on Wednesday reported a loss of $8.5 million in its fourth quarter.
On a per-share basis, the Holon, Israel-based company said it had a loss of 17 cents.
The drug developer posted revenue of $53,000 in the period.
For the year, the company reported that its loss widened to $31.5 million, or 62 cents per share. Revenue was reported as $712,000.
The company's shares closed at $4.65. A year ago, they were trading at $4.72.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGEN at https://www.zacks.com/ap/CGEN
Keywords: Compugen, Earnings Report